Abstract
Purpose
Rapid increases in testicular cancer incidence have marked the second half of the last century. While these secular rises, observed mainly in countries attaining the highest levels of human development, appear to have attenuated in the last decade, rates continue to increase in countries transiting toward high developmental levels. The purpose of our study was to provide a comprehensive analysis and presentation of the cohort-specific trends in testicular cancer incidence rates in 38 countries worldwide.
Methods
We used an augmented version of the Cancer Incidence in Five Continents series to analyze testicular cancer incidence in men aged 15–54 in 38 countries, via age–period–cohort analysis.
Results
In many European countries, the USA, Canada, Australia, and New Zealand, there is a continuation of the increasing risk among successive generations, yet rates are attenuating in male cohorts born since the 1970s in several Northern European countries, in contrast to the steeply increasing trends in recent cohorts in Southern Europe. Incidence rates have also been increasing in the populations traditionally at rather low risk, such as in the Philippines, Singapore, China, and Costa Rica.
Conclusions
The attenuation of testicular cancer risk in younger generations (in the most developed countries) alongside concomitant increases (in countries undergoing developmental change) is indicative of a global transition in the risk of testicular cancer. While identifying the underlying causes remains a major challenge, increasing awareness and adapting national healthcare systems to accommodate a growing burden of testicular cancer may prevent future avoidable deaths in young men.
Abbreviations
- CI5:
-
Cancer Incidence in Five Continents
- APC:
-
Age–period–cohort
References
Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Moller H (2006) Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality. Int J Cancer 118(12):3099–3111
Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19(5):1151–1159
Ferlay J, Soerjomataram I, Ervik M, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France. http://globocan.iarc.fr
Bergstrom R, Adami HO, Mohner M et al (1996) Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727–733
Bray F, Richiardi L, Ekbom A et al (2006) Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries. Cancer Epidemiol Biomarkers Prev 15(4):652–658
Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13(12):2157–2166
Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW (2008) Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer 122(3):639–642
Kanetsky PA, Mitra N, Vardhanabhuti S et al (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat Genet 41(7):811–815
Chung CC, Kanetsky PA, Wang Z et al (2013) Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 45(6):680–685
Ruark E, Seal S, McDonald H et al (2013) Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14. Nat Genet 45(6):686–689
McGlynn KA (2001) Environmental and host factors in testicular germ cell tumors. Cancer Invest 19(8):842–853
Garner MJ, Turner MC, Ghadirian P, Krewski D (2005) Epidemiology of testicular cancer: an overview. Int J Cancer 116(3):331–339
Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2009) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the mother. Int J Epidemiol 38(6):1532–1542
Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618
Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F (2011) Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 60(1):1–15
Levi F, La Vecchia C, Boyle P, Lucchini F, Negri E (2001) Western and eastern European trends in testicular cancer mortality. Lancet 357(9271):1853–1854
Znaor A, Lortet-Tieulent J, Jemal A, Bray F (2013) International variations and trends in testicular cancer incidence and mortality. Eur Urol. doi:10.1016/j.eururo.2013.11.004
Znaor A, Bray F (2012) Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West. Acta Oncol 51(7):956–958
Bertuccio P, Malvezzi M, Chatenoud L et al (2007) Testicular cancer mortality in the Americas, 1980–2003. Cancer 109(4):776–779
McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97(1):63–70
Ferlay J, Parkin DM, Curado MP, Bray F, Edwards B, Shin HR, Forman D (2010) Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9. International Agency for Research on Cancer, Lyon, France. http://ci5.iarc.fr
Doll R, Payne P, Waterhouse J (1966) Cancer incidence in five continents, vol I. Union Internationale Contre le Cancer, Geneva, Switzerland
Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6(4):449–467
Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II: age–period–cohort models. Stat Med 6(4):469–481
Rutherford M, Lambert P, Thompson J (2010) Age-Period-cohort modelling. Stata J 10(4):606–627
StataCorp LP (2011) Stata statistical software. College Station, TX
Skakkebaek NE, Rajpert-De ME, Jorgensen N et al (2007) Testicular cancer trends as ‘whistle blowers’ of testicular developmental problems in populations. Int J Androl 30(4):198–204
Skakkebaek NE, Berthelsen JG, Giwercman A, Muller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10(1):19–28
Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81(21):1668–1669
Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23(1):8–13
Le Cornet C, Lortet-Tieulent J, Forman D et al (2013) Testicular cancer incidence to rise by 25 % by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer 50(4):831–839
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Znaor, A., Lortet-Tieulent, J., Laversanne, M. et al. International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990. Cancer Causes Control 26, 151–158 (2015). https://doi.org/10.1007/s10552-014-0486-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-014-0486-z